Skip to main content

Daniel F Hanley

NIH Rank #156
  • Top 1% Funded
  • R01 Holder
  • Early Career

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID 7760988Search this ID in NIH RePORTER
ScienceDex PI coverage
FY2024 through FY2026Career claims are limited to the years shown.

FY2026 award categories

  • Internal Medicine
  • Neurology

NIH Funding · FY2025

Linked Award Amount
$17.2M
Full award amounts, FY2025
Award Records
6
Records listing this PI
Award-Linked Rank
#156
By linked amount among FY2025 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Daniel F Hanley. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2025 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2025 award records by amount

NIH award records listing Daniel F Hanley as a PI. Multi-PI records show the full award amount for context.

  • 5R01AG062624-05R01
    Metformin in Alzheimer's dementia Prevention (MAP)
    $6.5M
    award amount
  • 5U24TR004440-03U24
    Johns Hopkins University Trial Innovation Center
    $4.9M
    award amount
  • 5U24TR004316-04U24
    Johns Hopkins Statistical and Safety Resource Center-HEAL PAIN ERN
    $2.2M
    award amount
  • 5U24HL165066-04U24
    2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation
    $1.5M
    award amount
  • 5R01AG069930-05R01
    BEACH: Biomarker and Edema Attenuation in IntraCerebral Hemorrhage Phase 2a Trial
    $1.4M
    award amount
  • 1U24HL173399-01A1U24
    ASTRO: Adjuvant STeroid Outcomes in idiopathic subglottic stenosis: A randomized trial
    $921K
    award amount

Award organizations

Organizations that administered FY2025 awards listing Daniel F Hanley as a PI.

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2024
    First NIH Award
    Johns Hopkins University
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    $5M Cumulative Funding
  6. 2024
    $10M Cumulative Funding
  7. 2024
    Entered Top 50% Nationally
    Ranked #315
  8. 2024
    Entered Top 25% Nationally
    Ranked #315
  9. 2024
    Entered Top 10% Nationally
    Ranked #315
  10. 2024
    Entered Top 5% Nationally
    Ranked #315
  11. 2025
    $25M Cumulative Funding
  12. 2025
    Entered Top 1% Nationally
    Ranked #156
  13. 2025
    Multi-Institutional Research
    Awards at 2 institutions
  14. 2025
    R01 Grant Holder